Category: Forschung
Publication on cross-professional medication management
Medication management comprises the control and monitoring of the medication process from prescription to administration of the medication. Medication management can be used to identify and rectify application errors, adherence problems or adverse drug events. Cross-professional medication management also includes medical (e.g. diagnoses) and nursing (e.g. care, care level) data. This allows medication to be…
AmbulanzPartner in the trade journal NeuroTransmitter
AmbulanzPartner is featured in the current issue of the specialist journal NeuroTransmitter (1/2016 supplement). NeuroTransmitter sees itself as a discussion forum and leading professional-political medium for neurologists, neurologists and psychiatrists in Germany. As the organ of three professional associations, NeuroTransmitter is a must-read for neurologists and neurologists. Our aim with this article is to provide…
Managing Aftercare for Stroke II Study: OutpatientPartner for the recording of long-term care
In the second phase of the study on post-rehabilitative disability due to stroke and patient needs (“MAS II“), AmbulanzPartner will be used to digitally record the long-term care of the study participants. MAS II is being conducted by the Charité’s Center for Stroke Research Berlin (CSB) and will begin in June 2016. The CSB wants…
Publication of supply data in the area of medical aids from the AmbulanzPartner network
A first scientific evaluation of aggregated care data from the Outpatient Partner Network was published this month in “Der Nervenarzt” – the official publication of the German Society of Neurology (DGN). The publication analyzes data on the provision of assistive devices for patients with amyotrophic lateral sclerosis (ALS) in the period from June 2011 to…
Smart Home Berlin: Press trip with Berlin Senator for Health and Social Affairs and AmbulanzPartner
The Berlin Technology Foundation organized a press trip with Berlin’s Senator for Health and Social Affairs, Mario Czaja, together with AmbulanzPartner to present the “Smart Home Berlin” study on 01.04.2015. During the press trip, AmbulanzPartner was presented as an example of an innovative care technology developed in Berlin. The recently published study “Smart Home Berlin”…
Presentation of the “Empowerment Award for People with ALS 2014” on 07.12.2014
The “Empowerment Prize for People with ALS 2014” will be awarded on December 7, 2014. The prize recognizes the achievements of patients participating in a self-assessment study for amyotrophic lateral sclerosis (ALS). The Empowerment Award highlights the importance of patient evaluations in optimizing existing therapies and further developing future treatment methods. The aim of the…
Science prize from the German Neurological Society for the network of ALS outpatient clinics and AmbulanzPartner
During this year’s annual conference of the German Society of Neurology (DGN) in Munich, the DGN poster prize in the motor neuron and muscle diseases category was awarded to a consortium of university ALS outpatient clinics and AmbulanzPartner. The award was given for the scientific contribution ‘Provision of aidsin ALS – analysis from 3 years…
AmbulanzPartner at the DEMOGRAFIEKONGRESS 2014 in Berlin
AmbulanzPartner will be presenting its internet-supported care management system at the DEMOGRAFIEKONGRESS 2014. The congress will take place from September 4 to 5, 2014 in Berlin and will focus on shaping demographic change processes in Germany. The cooperation partners of the DEMOGRAPHY CONGRESS are the German Association of Towns and Municipalities, the German County Association,…
Three years of internet-based supply management of medical aids with AmbulanzPartner – presentation at Neurowoche 2014
At the Neurowoche 2014 together with the 87th Congress of the German Society of Neurology (DGN) on September 16, 2014 in Munich, the results of three years of Internet-based care management of assistive devices in amyotrophic lateral sclerosis (ALS) with AmbulanzPartner will be presented in the scientific program.Background: ALS is a prototypical disease for the…
